Genomic Information Articles & Analysis
34 news found
However, genome engineering is a slow, inefficient, and arduous process that limits microbial producers. The emerging Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system has greatly improved the efficiency of genome editing and simplified multilocus genome editing steps. It has also enabled the rapid disruption of metabolic ...
Unlike DNA and viral vectors, mRNA will not be inserted into the host genomes that modify genetic information, and proteins encoded by mRNA fragments will only be expressed instantaneously and then degraded rapidly, minimizing the risk of gene integration and being highly safe. ...
Information mining of metatranscriptome data by bioinformatics, and analysis of microbial species, genes, and pathways from G-based high-throughput sequencing data. ...
More importantly, co-infection between these new SARS-CoV-2 strains and other viruses (e.g. influenza, monkeypox, etc.) as well as bacteria can increase strain on a patient’s immune system and cause still further mutations as the co-infected pathogens share genomic information between each other.” ...
CD Genomics, a world-leading genomics services company, today announced that members of its management team will participate in the BIO International Convention on June 13-16th, 2022, in San Diego, California. ...
MiXCR 4.0 is enhanced software for analysis of genomics data and building a comprehensive picture of the immune response. Leading pharmaceutical research and development (R&D) teams can leverage MiXCR 4.0 for drug discovery pipelines, and for analyzing DNA sequencing data unraveling genomic information about antibodies, T-cell, and B-cell ...
This testing service will provide essential genomic information through comprehensive genomic profiling (CGP) for patients with any solid cancerous tumor. ...
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. ...
An exploratory analysis from the PREDATOR study of metastatic colorectal cancer (mCRC) patients undergoing surgicalAuthors (in order): Halla Nimeiri1, Amanda Young1, Russell Madison1, Alexander Fine1, Ole Gjoerup1, Fotios Loupakis2, Matteo Fassan2,3, Sara Lonardi2, Shruti Sharma4, Hsin-Ta Wu4, Alexey Aleshin4, Elise Renkonen1, Priti Hegde11Foundation Medicine Inc, 2Istituto Oncologico Veneto ...
Our blood-based tests can overcome these barriers and provide fast and actionable information to help guide treatment decisions across the continuum of ...
DNA methylation is established and maintained by DNA methyltransferases (DNMT1, DNMT3a, and DNMT3b). CD Genomics uses a mature high-throughput sequencing platform combined with epigenetics to provide a variety of biological information analysis services such as genome-wide epigenetic location analysis and gene expression regulation mechanism ...
In 2016, he was awarded the National Medal of Technology and Innovation for his “pioneering inventions and commercialization of next-generation DNA sequencing technologies, making access to genomic information easier, faster, and more cost-effective for researchers around the ...
The second-generation sequencing technology can quickly and comprehensively obtain the sequence information and expression information of almost all transcripts of a specific cell or tissue in a certain state. ...
The collaboration aims to provide patients and their oncologists with more information as to what therapies could be most effective in treating their cancer. ...
“We believe all patients living with advanced cancer should benefit from comprehensive genomic profiling to inform their care and these agreements are an important step forward in making that happen through improved access to testing,” said Brian Alexander, MD, MPH, chief executive officer at Foundation Medicine. ...
She has contributed to more than 90 publications on cancer and led the development of My Cancer Genome, an international knowledge resource for precision medicine that provides accessible information to patients and physicians around cancer-driving mutations, clinical trials, and therapies. ...
With a recently closed $60 million funding round, the acquisition of software company Dropprint Genomics, and additions to its leadership team, immune profiling firm Immunai is looking to expand its functional genomics capabilities to more directly inform immune therapy development and application. ...
ByImmunai
Bioinformatics methods suffer from a significant loss of accuracy when used on sequencing data from under-represented populations because the genetic information of such populations cannot be captured in the linear reference genome. The inherent bias in the industry’s current reference genome favors the European population. A ...
The EPI test is a non-invasive, urine-based genomic test that helps inform the prostate biopsy decision. This liquid biopsy test continues to expand its presence and usage among urologists and primary care physicians in the US. ...
Through its partnership with Bamburgh Capital, MIJ is particularly focused on identifying investment opportunities in the UK, where MIJ is attracted by the compelling opportunities to invest in innovative companies opening up world-class science and supported by collaborative, informed and influential ecosystems. Japan is the third largest healthcare market in the world and MIJ ...